Skip to main content

Citius Pharmaceuticals, Inc.

CTXR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001506251

No open-market purchases or sales by Citius Pharmaceuticals, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $822.4K in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Citius Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
28
−1 vs. Q4 2024
Shares held
635.5K
−4.06K (−0.6%) vs. Q4 2024
Total value
$947.2K
−$1.48M (−61.0%) vs. Q4 2024
New holders
5
7 more added
Sold out
6
8 more reduced

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CTXR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 28 institutions
Q1 2021: 39 institutionsQ2 2021: 74 institutionsQ3 2021: 71 institutionsQ4 2021: 77 institutionsQ1 2022: 76 institutionsQ2 2022: 60 institutionsQ3 2022: 57 institutionsQ4 2022: 54 institutionsQ1 2023: 56 institutionsQ2 2023: 75 institutionsQ3 2023: 74 institutionsQ4 2023: 74 institutionsQ1 2024: 73 institutionsQ2 2024: 72 institutionsQ3 2024: 58 institutionsQ4 2024: 30 institutionsQ1 2025: 28 institutionsQ2 2025: 31 institutionsQ3 2025: 34 institutionsQ4 2025: 39 institutionsQ1 2026: 38 institutionsQ2 2026: 42 institutions
Value heldQ1 2025: $947.2K
Q1 2021: $19.3MQ2 2021: $87.6MQ3 2021: $51.1MQ4 2021: $37.6MQ1 2022: $43.2MQ2 2022: $14.0MQ3 2022: $16.6MQ4 2022: $11.2MQ1 2023: $16.9MQ2 2023: $30.4MQ3 2023: $17.1MQ4 2023: $20.3MQ1 2024: $24.2MQ2 2024: $17.9MQ3 2024: $11.8MQ4 2024: $2.43MQ1 2025: $947.2KQ2 2025: $1.48MQ3 2025: $773.2KQ4 2025: $1.34MQ1 2026: $896.9KQ2 2026: $822.4K
Institutions holding CTXR and their total value by quarter
QuarterHoldersValue
Q2 202642$822.4K
Q1 202638$896.9K
Q4 202539$1.34M
Q3 202534$773.2K
Q2 202531$1.48M
Q1 202528$947.2K
Q4 202430$2.43M
Q3 202458$11.8M
Q2 202472$17.9M
Q1 202473$24.2M
Q4 202374$20.3M
Q3 202374$17.1M
Q2 202375$30.4M
Q1 202356$16.9M
Q4 202254$11.2M
Q3 202257$16.6M
Q2 202260$14.0M
Q1 202276$43.2M
Q4 202177$37.6M
Q3 202171$51.1M
Q2 202174$87.6M
Q1 202139$19.3M

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Citius Pharmaceuticals, Inc.; share changes are against Q4 2024.

Institutions holding CTXR in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc257,631$383.9K0.00%00.0%Unchanged
Geode Capital Management, LLC89,275$133.0K0.00%+12,769+16.7%Added
BlackRock, Inc.72,227$107.6K0.00%00.0%Unchanged
UBS Group AG67,215$100.2K0.00%+39,648+143.8%Added
Squarepoint Ops LLC60,983$90.9K0.00%+11,315+22.8%Added
State Street Corp23,271$34.7K0.00%00.0%Unchanged
Northern Trust Corp15,173$22.6K0.00%+2,400+18.8%Added
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors14,000$21.7K0.00%+14,000New
Arkadios Wealth Advisors10,000$14.9K0.00%00.0%Unchanged
IFP Advisors, Inc7,083$10.6K0.00%−33,333−82.5%Reduced
Chelsea Counsel Co4,626$6.89K0.00%+4,626New
Tower Research Capital LLC (TRC)4,410$6.57K0.00%−3,802−46.3%Reduced
Group One Trading, L.P.3,342$4.98K0.00%−1,475−30.6%Reduced
SBI Securities Co., Ltd.2,268$3.38K0.00%−14−0.6%Reduced
Advisor Group Holdings, Inc.1,527$2.27K0.00%00.0%Unchanged
Simplex Trading, LLC966$1.00K0.00%−754−43.8%Reduced
Luminist Capital LLC435$5220.00%+95+27.9%Added
Princeton Global Asset Management LLC160$2380.00%00.0%Unchanged
Murphy & Mullick Capital Management Corp160$2380.00%00.0%Unchanged
JPMorgan Chase & Co136$2030.00%+12+9.7%Added
Smallwood Wealth Investment Management, LLC120$1780.00%+120New
Quent Capital, LLC108$1610.00%00.0%Unchanged
BNP Paribas Arbitrage, SA107$1590.00%−14−11.6%Reduced
Federation des caisses Desjardins du Quebec80$1190.00%+80New
Bank of America Corp68$1010.00%+13+23.6%Added
Morgan Stanley60$890.00%−258−81.1%Reduced
Fairscale Capital, LLC42$630.00%−324−88.5%Reduced
Barclays PLC29$430.00%+29New
Millennium Management LLC0$00.00%−32,320−100.0%Sold out
Fisher Asset Management, LLC0$00.00%−12,800−100.0%Sold out
Royal Bank of Canada0$00.00%−4,000−100.0%Sold out
Citigroup Inc0$00.00%−73−100.0%Sold out
Danske Bank A/S0$00.00%−2−100.0%Sold out
Citadel Advisors LLC0$00.00%−1−100.0%Sold out
WR Wealth Planners, LLC––––Not filed